StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > AND DOWN WE GO AGAIN

<< Previous

Bullboard Posts

Next >>

Comment by Stockish12on Jan 19, 2021 4:20pm

152 Views

Post# 32329095

RE:RE:RE:RE:AND DOWN WE GO AGAIN

How do I explain this to this kid?

ARISTOTLE IS A GREAT PRODUCT. I am invested cos of the product. My average is .06 pre consolidation. I sold a lot between $1.2 and $1.35 to get my principal with lots of profit.

Whats left is what I am willing to risk. That is the risk I am willing to take.

I am thinking you are not vast with NASDQ/NYSE investments. If you were, you will not be arguing on the fact that Tripp has the capacity to float a company on either of those exchanges. Shorts will have him and aristotle for a meal.

It takes more than the product dumbass.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec